[Congressional Record Volume 168, Number 120 (Wednesday, July 20, 2022)]
[Senate]
[Page S3529]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




EXPRESSING SUPPORT FOR THE DESIGNATION OF JULY 2022 AS NATIONAL SARCOMA 
                            AWARENESS MONTH

  Mr. SCHUMER. Mr. President, I ask unanimous consent that the 
Committee on Health, Education, Labor, and Pensions be discharged from 
further consideration and the Senate now proceed to S. Res. 694.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The clerk will report the resolution by title.
  The senior assistant legislative clerk read as follows:

       A resolution (S. Res. 694) expressing support for the 
     designation of July 2022 as ``National Sarcoma Awareness 
     Month''.

  There being no objection, the committee was discharged, and the 
Senate proceeded to consider the resolution.
  Mr. SCHUMER. I ask unanimous consent the resolution be agreed to, the 
Johnson amendment to the preamble at the desk be agreed to, that the 
preamble as amended be agreed to, and that the motions to reconsider be 
considered made and laid upon the table.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The resolution (S. Res. 694) was agreed to.
  The amendment (No. 5143) was agreed to as follows:

                   (Purpose: To amend the preamble.)

       In paragraph (2) of the second whereas clause of the 
     preamble, strike ``7,000'' and insert ``7,200''.
       In paragraph (3) of the second whereas clause of the 
     preamble, strike ``any 1 time'' and insert ``any given 
     time''.
       In the third whereas clause of the preamble, strike ``20'' 
     and insert ``15''.
  The preamble, as amended, was agreed to.
  The resolution, with its preamble, as amended, reads as follows:

                              S. Res. 694

       Whereas sarcoma is a rare cancer of the bones or connective 
     tissues, such as nerves, muscles, joints, fat, and blood 
     vessels, that can arise nearly anywhere in the body;
       Whereas, in the United States--
       (1) about 16,000 individuals are diagnosed with sarcoma 
     each year;
       (2) approximately 7,200 individuals die from sarcoma each 
     year; and
       (3) about 50,000 individuals struggle with sarcoma at any 
     given time;
       Whereas, each year, about 1 percent of cancers diagnosed in 
     adults and around 15 percent of cancers diagnosed in children 
     are sarcoma;


 =========================== NOTE =========================== 

  
  On page S3529, July 20, 2022, second column, the following 
appears: (2) approximately 7,000 individuals die from sarcoma each 
year; and (3) about 50,000 individuals struggle with sarcoma at 
any 1 time; Whereas, each year, about 1 percent of cancers 
diagnosed in adults and around 20 percent of cancers diagnosed in 
children are sarcoma;
  
  The online Record has been corrected to read: (2) approximately 
7,200 individuals die from sarcoma each year; and (3) about 50,000 
individuals struggle with sarcoma at any given time; Whereas, each 
year, about 1 percent of cancers diagnosed in adults and around 15 
percent of cancers diagnosed in children are sarcoma;


 ========================= END NOTE ========================= 


       Whereas more than 70 subtypes of sarcoma have been 
     identified;
       Whereas the potential causes of sarcoma are not well 
     understood;
       Whereas treatment for sarcoma can include surgery, 
     radiation therapy, or chemotherapy;
       Whereas sarcoma is often misdiagnosed and underreported; 
     and
       Whereas July 2022 would be an appropriate month to 
     designate as National Sarcoma Awareness Month--
       (1) to raise awareness about sarcoma; and
       (2) to encourage more individuals in the United States to 
     get properly diagnosed and treated: Now, therefore, be it
       Resolved, That the Senate supports the designation of July 
     2022 as ``National Sarcoma Awareness Month''.

     

                          ____________________